Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent vs Delayed H1N1 and Seasonal Influenza Vaccination
NCT01000584Phase 4Completed
- Start
- Nov 2009
- Primary completion
- Feb 2010
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines, Cancer Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) in Influenza A H1N1 (H1N1) (2 arms). Primary endpoints: Occurrence of adverse events and Occurrence of serious adverse events and other significant health events. Started Nov 2009; status: completed.
02
Drugs
Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
03
Conditions
Influenza A H1N1 (H1N1)
Beyond the preview
Go deeper on NCT01000584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01000584.